Response Biomedical (RBM.V) Gets CE Mark for the D-dimer Assay
11/7/2012 7:35:33 AM
More...
|
Response Biomedical (RBM.V) Regains Rights to Flu, RSV Tests After Termination of 3M Company (MMM) Deal
10/3/2012 6:53:44 AM
More...
|
Response Biomedical (RBM.V) Taps Jeffrey L. Purvin as New CEO
4/15/2012 10:01:26 PM
More...
|
Response Biomedical (RBM.V) Announces Leadership Changes
10/21/2011 10:04:51 AM
More...
|
Response Biomedical (RBM.V) Announces Restatement of Financial Statements
9/30/2011 10:12:57 AM
More...
|
Response Biomedical (RBM.V) Announces Termination of Sales and Distribution Agreement with Roche Diagnostics Corporation (ROG.VX)
9/2/2011 9:35:42 AM
More...
|
Response Biomedical (RBM.V) Announces Resignation of Chief Executive Officer, S. Wayne Kay
8/15/2011 8:59:13 AM
More...
|
Response Biomedical (RBM.V) Announces Second Quarter Results
8/10/2011 10:44:37 AM
More...
|
Response Biomedical (RBM.V) Receives Decision Regarding CLIA Waiver for RAMP(R) NT-proBNP Assay for Diagnosis of Heart Failure (HF)
6/13/2011 9:23:32 AM
More...
|
Response Biomedical (RBM.V) Enters Into Exclusive Canadian Distribution Agreement with Fisher Scientific Company
5/4/2011 10:46:13 AM
More...
|
|